Randomized crossover pharmacokinetic evaluation of subcutaneous versus intravenous granisetron in cancer patients treated with platinum-based chemotherapy

Randomized crossover pharmacokinetic evaluation of subcutaneous versus intravenous granisetron in cancer patients treated with platinum-based chemotherapy

BACKGROUND: 5-HT3-receptor antagonists are one of the mainstays of antiemetic treatment, and they are administered either i.v. or orally. Nevertheless, sometimes neither administration route is feasible, such as in patients unable to admit oral intake managed in an outpatient setting. Our objecti...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Gurpide, A. (Alfonso), Sadaba, B. (Belén), Martin-Algarra, S. (Salvador), Azanza, J.R. (José Ramón), Lopez-Picazo, J.M. (José M.), Campanero, M.A. (Miguel Angel), Cabello, J.P. (J.P.), Gil-Aldea, I. (I.), Cruz, S. (S.) de la, Fernandez-Gallego, V. (V.), Reyna, C. (Carmen), Olier, C. (Clara), Blanco-Prieto, M.J. (María José), Ceballos-Viro, J. (Jaime), Garcia-Foncillas, J. (Jesús), Perez-Gracia, J.L. (Jose Luis)
التنسيق: info:eu-repo/semantics/article
اللغة:eng
منشور في: AlphaMed Press 2011
الموضوعات:
Emesis
Granisetron
Pharmacokinetics
Subcutaneous
الوصول للمادة أونلاين:https://hdl.handle.net/10171/19115

الانترنت

https://hdl.handle.net/10171/19115

مواد مشابهة